Tue, June 19, 2018
Mon, June 18, 2018
Fri, June 15, 2018
Thu, June 14, 2018
Wed, June 13, 2018
Tue, June 12, 2018
Mon, June 11, 2018
Fri, June 8, 2018
Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018
Mon, June 4, 2018
Fri, June 1, 2018
Thu, May 31, 2018
Wed, May 30, 2018
Tue, May 29, 2018
Fri, May 25, 2018
Thu, May 24, 2018
Wed, May 23, 2018
Tue, May 22, 2018

David Novak Maintained (ZYME) at Buy with Increased Target to $27 on, Jun 5th, 2018


//stocks-investing.news-articles.net/content/201 .. with-increased-target-to-27-on-jun-5th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


David Novak of Raymond James, Maintained "Zymeworks Inc." (ZYME) at Buy with Increased Target from $22 to $27 on, Jun 5th, 2018.

David has made no other calls on ZYME in the last 4 months.



There are 2 other peers that have a rating on ZYME. Out of the 2 peers that are also analyzing ZYME, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Upgraded from Sell to Hold on, Friday, May 11th, 2018


This is the rating of the analyst that currently disagrees with David


  • Jim Birchenough of "Wells Fargo" Maintained at Buy with Increased Target to $37 on, Monday, June 4th, 2018

Publication Contributing Sources